Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Japanese encephalitis
NITAG documentation
2022
Western Pacific
Clear all
Type of publications
NITAG documentation
(12)
Systematic reviews (SYSVAC)
(6)
Topics
Recommendation
(12)
Available to download in languages
English (EN)
(11)
Regions
Western Pacific
(12)
Africa
(5)
Americas
(31)
Europe
(26)
Countries
Australia
(12)
Diseases
COVID-19
(11)
Japanese encephalitis
(1)
Mpox // Monkeypox
(1)
Vaccine topics
Target population
Children
(1)
Methodological quality (AMSTAR 2)
Publication date
2022
(12)
2023
(5)
2021
(11)
2020
(2)
12 results found
2022
∙
ATAGI
ATAGI statement on the intradermal use of Imojev Japanese encephalitis vaccine
2022
∙
ATAGI
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine
2022
∙
ATAGI
ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years
2022
∙
ATAGI
COVID-19 vaccination – Guidance on myocarditis and pericarditis after COVID-19 vaccines
2022
∙
ATAGI
ATAGI statement on use of the Moderna bivalent Original/Omicron vaccine
2022
∙
ATAGI
Novavax vaccine for adolescents aged 12-17 years
2022
∙
ATAGI
ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years
2022
∙
ATAGI
ATAGI recommendations on the use of a booster dose of COVID-19 vaccine
2022
∙
ATAGI
ATAGI statement on defining 'up-to-date' status for COVID-19 vaccination
2022
∙
ATAGI
ATAGI statement on recommendations on a winter booster dose of COVID-19 vaccine
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register